Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2025-12-25 @ 4:02 AM
NCT ID:
NCT03601702
Eligibility Criteria:
Inclusion Criteria
* Signed Informed Consent Form
* Large Vessel Occlusion on CTA or MRA in the Anterior or Posterior Proximal Cerebral Vasculature up to A1, M1, Dominant M2, P1
* ASPECTS ≥ 6
* Mismatch or good collaterals showed at MR or multiphasic CTA or pCT
* Groin Puncture performed within 12 hours from symptom onset
* Use of EmboTrap® II Revascularization Device (Neuravi) as the first or second line treatment
Exclusion criteria
* Informed consent not given
* Extracranial or tandem occlusion
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03601702
Study Brief:
Protocol Section:
NCT03601702